Kadimastem Market Risk Adjusted Performance

KDST Stock  ILA 485.00  35.00  6.73%   
Kadimastem market-risk-adjusted-performance technical analysis lookup allows you to check this and other technical indicators for Kadimastem or any other equities. You can select from a set of available technical indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations and data normalization technicques. Please check also Equity Screeners to view more equity screening tools
  
Kadimastem has current Market Risk Adjusted Performance of 0.7691.

MRAP

 = 

ER[a] + (1/BETA - 1)

X

ER[a] - RFR)

 = 
0.7691
ER[a] = Expected return on investing in Kadimastem
RFR = Risk Free Rate of return. Typically T-Bill Rate
BETA = Beta of the asset with market or selected benchmark.

Kadimastem Market Risk Adjusted Performance Peers Comparison

Kadimastem Market Risk Adjusted Performance Relative To Other Indicators

Kadimastem is rated second overall in market risk adjusted performance category among related companies. It is currently under evaluation in maximum drawdown category among related companies reporting about  38.42  of Maximum Drawdown per Market Risk Adjusted Performance. The ratio of Maximum Drawdown to Market Risk Adjusted Performance for Kadimastem is roughly  38.42 
Compare Kadimastem to Peers

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Thematic Ideas
Explore Investing Ideas